Intel's (INTC) recent rally isn't the only one investors should pay attention to, says Diane King Hall. She points to Moderna (MRNA) hitting a 52-week high after a trial drug to treat melanoma posted positive results. On the earnings front, Diane explains why investors are shaking off Procter & Gamble's (PG) mixed earnings and Abbott's (ABT) post-earnings sell-off.